0.00Open1.00Pre Close0 Volume18 Open Interest1.00Strike Price0.00Turnover194.87%IV3.36%PremiumSep 20, 2024Expiry Date0.94Intrinsic Value100Multiplier25DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.9404Delta0.1194Gamma1.98Leverage Ratio-0.0024Theta0.0006Rho1.87Eff Leverage0.0006Vega
Compugen Stock Discussion
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
No comment yet